You may also like these news :
LegalView Unveils Two New Practice Areas Regarding Cholesterol Drugs Vytorin and Zetia
LegalView launched two new practice areas on the cholesterol drugs Vytorin and Zetia, which were recently cited in a study as providing no benefit on arterial plaque compared to the generic versions available. Zetia and Vytorin specifically, are more expensive than other versions of cholesterol drugs. (PRWeb Jan 28, 2008) Post Comment:Trackback URL: http://www.prweb.com/pingpr.php/UHJvZi1FbXB0LUZhbHUtRW1wdC1aZXRhLVplcm8=